Search

Your search keyword '"Reed JC"' showing total 59 results

Search Constraints

Start Over You searched for: Author "Reed JC" Remove constraint Author: "Reed JC" Topic caspases Remove constraint Topic: caspases
59 results on '"Reed JC"'

Search Results

1. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.

2. Protective role of Cop in Rip2/caspase-1/caspase-4-mediated HeLa cell death.

3. Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases.

4. Tumor-associated alterations in caspase-14 expression in epithelial malignancies.

5. Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells.

6. Components of the cell death machine and drug sensitivity of the National Cancer Institute Cell Line Panel.

7. Early processing of Bid and caspase-6, -8, -10, -14 in the canine brain during cardiac arrest and resuscitation.

8. Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.

9. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation.

10. Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein.

11. Contribution of caspase-8 to apoptosis of axotomized rat retinal ganglion cells in vivo.

12. The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1 regulation.

13. A method for functional evaluation of caspase activation pathways in intact lymphoid cells using electroporation-mediated protein delivery and flow cytometric analysis.

14. Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy.

15. Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1.

16. Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome.

17. Apotosis-related proteins in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix.

18. Caspases 3 and 9 send a pro-apoptotic signal from synapse to cell body in olfactory receptor neurons.

19. Temporal and spatial profile of caspase 8 expression and proteolysis after experimental traumatic brain injury.

20. A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis.

21. TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis.

22. Studies of apoptosis proteins in yeast.

23. Caspase-9: involvement in secondary death of axotomized rat retinal ganglion cells in vivo.

24. Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia.

25. Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases.

26. Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells.

27. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis.

28. Nuclear localization of procaspase-9 and processing by a caspase-3-like activity in mammary epithelial cells.

29. Correlation between structure of Bcl-2 and its inhibitory function of JNK and caspase activity in dopaminergic neuronal apoptosis.

30. BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins.

32. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases.

33. Expression of caspase-3 in brains from paediatric patients with HIV-1 encephalitis.

34. Dysregulation of apoptosis in cancer.

35. Characterization of caspase processing and activation in HL-60 cell cytosol under cell-free conditions. Nucleotide requirement and inhibitor profile.

36. Postmitochondrial regulation of apoptosis during heart failure.

37. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia.

38. Caspase-9 can be activated without proteolytic processing.

39. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner.

41. Mechanisms of apoptosis avoidance in cancer.

42. Investigation of glucocorticoid-induced apoptotic pathway: processing of caspase-6 but not caspase-3.

43. Regulation of cell death protease caspase-9 by phosphorylation.

44. Pro-caspase-3 is a major physiologic target of caspase-8.

45. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.

46. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases.

47. A single BIR domain of XIAP sufficient for inhibiting caspases.

48. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells.

49. Granzyme release and caspase activation in activated human T-lymphocytes.

50. BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases.

Catalog

Books, media, physical & digital resources